MABS 2017, VOL. 9, NO. 1, 1–4 http://dx.doi.org/10.1080/19420862.2016.1250055

EDITOR’S CORNER

Note of appreciation to reviewers Janice M. Reichert, Editor-in-Chief ARTICLE HISTORY Received 15 October 2016; Accepted 15 October 2016 KEYWORDS mAbs; Peer review

As we begin a new year, the Editorial Board, Associate and Assistant Editors, and Editor-in-Chief of mAbs would like to thank the reviewers who contributed their insights and advice, as well as suggestions for improvement of manuscripts submitted for publication in 2016. The peer-review process involved the investment of substantial time and effort by the experts listed below, and we sincerely appreciate their valuable input on the selection of relevant, high-quality articles for mAbs’ readers.

Name Adams, Timothy E. Agnello, Giulia Agrawal, Neeraj Alley, Steve Altmann, Friedrich Arntzen, Charles Arvinte, Tudor Bailey-Kellogg, Chris Balland, Alain Barb, Adam Beck, Alain Bennett, Eric Bernardes, Gon¸c alo Blein, Stanislas Bloom, Laird Boesch, Austin Bolmer, Sally Bondarenko, Pavel Bracewell, Daniel Bradfute, Steven Brezski, Randall Brinkmann, Ulrich Brocchini, Steve Buchner, Johannes Bussiere, Jeanine Cao, Xiang Cao, Yanguang Chari, Ravi Chen, Guodong Cheng, Lei Chiu, Mark Chowdhury, Partha Christ, Daniel Christianson, Gregory Chung, Shan Collin, Mattias Cox, Vivienne Cragg, Mark Crispin, Max Cunningham, Orla Curley, Michael Damelin, Marc Dave, Emma Davenport, Anthony Davis, Jonathan De Kruif, John

Institution Commonwealth Scientific and Industrial Research Organization Aeglea BioTherapeutics, Inc. Amgen Seattle Genetics, Inc. University of Natural Resources and Life Sciences Arizona State University University of Geneva and Therapeomic Inc. Basel Dartmouth College Boehringer Ingelheim Pharma GmbH & Co. KG Iowa State University Center d’Immunologie Pierre Fabre Pfizer Inc. University of Cambridge Glenmark Pharmaceuticals Pfizer Inc. Dartmouth College Independent consultant Amgen University College London The University of New Mexico Genentech Roche Pharma Research & Early Development University College London Technical University of Munich Amgen Bristol-Myers Squibb University of North Carolina Immunogen Bristol-Myers Squibb Nalco Champion, An Ecolab Company Janssen Research & Development, LLC MedImmune, Inc. Garvan Institute of Medical Research The Jackson Laboratory Genentech Lund University UK Bioscience Consultants University of Southampton University of Oxford Pfizer Inc. Merrimack Pharmaceuticals Pfizer Inc. UCB Pharma University of Cambridge Bristol-Myers Squibb Merus N.V.

Country Australia United States United States United States Austria United States Switzerland United States Germany United States France United States United Kingdom Switzerland United States United States United States United States United Kingdom United States United States Germany United Kingdom Germany United States United States United States United States United States United States United States United States Australia United States United States Sweden United Kingdom United Kingdom United Kingdom Ireland United States United States United Kingdom United Kingdom United States The Netherlands (Continued)

CONTACT Janice M. Reichert © 2017 Taylor & Francis

[email protected]

2

J. M. REICHERT

(Continued ) Name Demarest, Stephen Desoubeaux, Guillaume Dessain, Scott Dimitrov, Dimiter Dowlat, Hoss Doyle, Michael D€ ubel, Stefan Dumas, Bruno Dunbrack, Roland Eigenbrot, Charles Elowe, Sabine Escandon, Enrique Estep, Patricia Fazekas, Judit Fennell, Brian Florian, Cymer Fransson, Johan Georges, Guy Georgiou, George Gershoni, Jonathan Ghayur, Tariq Gill, Avinash Glanville, Jacob Gon¸c alves, Jo~ao Gu, Jijie Guillarme, Davy Guilleminault, Laurent Gupta, Manish Gurbaxani, Brian Gutka, Hiten Han, Bing Han, Liang Han, Linjie Harel, Efrat Harrer, Andrea He, Tao Higel, Fabian Hogg, Philip Honda, Shinya Hong, Qiuting Hotzel, Isidro Hus, Jean-Christophe Hust, Michael Ippolito, Gregory Ivanov, Andrejs Iyer, Suhasini Jacobson, Fred Jefferis, Roy Jones, Michael Junghans, Richard Junutula, Jagath Kelley, Robert Kellner, Christian Kettenberger, Hubert Kim, Yong-Sung King, Lindsay Klakamp, Scott Klein, Christian Koenig, Patrick Kohli, Neeraj Kolmar, Harald Kontermann, Roland Krammer, Florian Kremer, Leonor Kristensen, Peter Kulms, Dagmar Kunkel, Jeremy Kwok, Hang Fai Labrijn, Aran Leabman, Maya Leedham, Simon Leusen, Jeanette

Institution

Country

Eli Lilly and Company University of Tours Lankenau Institute for Medical Research National Institutes of Health PharmaBio Consulting Bristol-Myers Squibb Technische Universit€at Braunschweig Sanofi R&D Fox Chase Cancer Center Genentech Center de Recherche du CHUQ Merck and Co. Inc. Adimab, LLC Medical University of Vienna Pfizer Inc. F. Hoffmann-La Roche Northern Biologics Roche Pharma Research & Early Development University of Texas Tel Aviv University AbbVie Inc. Genentech Stanford Immunology / Distributed Bio Universidade Lisboa AbbVie Bioresearch Center University of Geneva Center d’Etude des Pathologies Respiratoires (Inserm U1100/EA 6305) Bristol-Myers Squibb Centers for Disease Control and Prevention Oncobiologics Inc. Eli Lilly and Company Boston University AbbVie Inc. University of California San Francisco Paracelsus Medical University Salzburg Pfizer Inc. Novartis University of Sydney National Institute of Advanced Industrial Science and Technology University of California Davis Genentech Biogen Technische Universit€at Braunschweig University of Texas at Austin Barts Cancer Institute AbbVie Biotherapeutics Inc. Genentech University of Birmingham Pfizer Inc. Tufts Medical Center Cellerant Therapeutics Genentech Christian-Albrechts-University of Kiel Roche Pharma Research & Early Development Ajou University Pfizer Inc. BiOptix Roche Pharma Research & Early Development AbbVie Stemcentrx LLC Merrimack Pharmaceuticals Technical University of Darmstadt University of Stuttgart Icahn School of Medicine at Mount Sinai Centro Nacional de Biotecnologia (CNB-CSIC) Aarhus University University of Dresden Health Canada University of Macau Genmab Genentech University of Oxford UMC Utrecht

United States France United States United States Germany United States Germany France United States United States Canada United States United States Austria Ireland Switzerland Canada Germany United States Israel United States United States United States Portugal United States Switzerland France United States United States United States United States United States United States United States Austria United States Germany Australia Japan United States United States United States Germany United States United Kingdom United States United States United Kingdom United States United States United States United States Germany Germany Republic of Korea United States United States Switzerland United States United States Germany Germany United States Spain Denmark Germany Canada Macau The Netherlands United States United Kingdom The Netherlands (Continued)

MABS

3

(Continued ) Name Li, Demin Lin, Jay Lin, Laura Liu, Hongcheng Liu, Margaret Liu, Wenhai L€ ofblom, John Lowe, David Lugovskoy, Alexey Luo, Shen Maiti, Sudipta Mapelli, Marina Marschall, Andrea Mathieu, Magali May, Chad Mazor, Ohad Meng, Weixu Metelitsa, Leonid Michelsohn, Arie Minter, Ralph Monnet, Celine Moorkens, Evelien Motohashi, Shinichiro Mounho-Zamora, Barbara Mukherjee, Somnath Nakamura, Gerald Nemeth, Jennifer Neri, Dario Ng, Chee-Keng Nikolov, Zivko Nissim, Ahuva Nixon, Andrew Obrezanova, Olga O’Callaghan, Peter Okeley, Nicole Owen, Shawn Palumbo, Alessandro Panwar, Rajiv Passot, Christophe Paubel, Pascal Penney, Mark Peppelenbosch, Maikel Pippig, Susanne Presta, Leonard Qi, Junpeng Rader, Christoph Raha, Tamal Reddy, Sai Respaud, Renaud Reusch, Dietmar Rispens, Theo Roberts, Christopher Robinson, Matthew Robinson, Matthew Rogers, Richard Rohde, Adelheid Rojas, Gertrudis Rouse, Jason Sandra, Koen Sapra, Puja Sazinsky, Steve Scheer, Justin Scherer, Thomas Schirrmann, Thomas Schlothauer, Tilman Schneider, Zita Senter, Peter Sepp, Armin Shah, Dhaval Shen, Yang Shi, Rong Shim, Hyunbo

Institution University of Oxford WuXi Apptec Pfizer Inc. Alexion University of Alabama at Birmingham Klus Pharma KTH Royal Institute of Technology MedImmune, Inc. Morphic Therapeutic Food and Drug Administration Tata Institute of Fundamental Research European Institute of Oncology Helmholtz-Zentrum f€ur Infektionsforschung Sanofi S.A Pfizer Inc. Israel Institute for Biological Research City of Hope National Medical Center Baylor College of Medicine Wiley Rein, LLP MedImmune, Inc. LFB Biotechnologies University of Leuven Chiba University ToxStrategies, Inc. University of Chicago Genentech Janssen Research & Development, LLC ETH Zurich, Philogen Pfizer Inc. Texas A&M University Queen Mary University of London Magenta Therapeutics Lonza Biologics Lonza Biologics Seattle Genetics, Inc. University of Utah Novartis Magenta Therapeutics Tours University Hospital University Paris Descartes, INSERM UMR S1145 UCB Erasmus Medical Center of Rotterdam Formycon AG Independent consultant The Scripps Research Institute The Scripps Research Institute Cipla BioTec Pvt. Ltd. ETH Zurich University of Tours Roche Diagnostics GmbH Sanquin University of Delaware Immunome, Inc. MedImmune, Inc. Just Biotherapeutics Roche Pharma Center of Molecular immunology Pfizer Inc. Research Institute for Chromatography Pfizer Inc. Jounce Therapeutics Boehringer Ingelheim Pharma GmbH & Co.KG Genentech YUMAB Roche Pharma Research & Early Development Texas A&M Seattle Genetics, Inc. GlaxoSmithKline Plc SUNY Buffalo Eli Lilly and Company Bristol-Myers Squibb Ewha Womans University

Country United Kingdom China United States United States United States United States Sweden United Kingdom United States United States India Italy Germany France United States Israel United States United States United States United Kingdom France Belgium Japan United States United States United States United States Switzerland United States United States United Kingdom United States United Kingdom United Kingdom United States United States United States United States France France United Kingdom The Netherlands Germany United States United States United States India Switzerland France Germany The Netherlands United States United States United Kingdom United States Switzerland Cuba United States Belgium United States United States United States United States Germany Germany United States United States United Kingdom United States United States United States Republic of Korea (Continued)

4

J. M. REICHERT

(Continued ) Name Sidhu, Sachdev Skerra, Arne Soman, Gopalan Sondermann, Peter Song, Zhiwei Souders, Colby Spahr, Christopher Spiess, Christoph Sridharan, Sid St. Croix, Brad Stagg, John Starkey, Jason Stefanich, Eric Strohl, William Sundaram, Shanmuuga Tam, Susan Tang, Liangjie Taube, Christian Taylor, Ronald Tetin, Sergey Theriault, Steven Tomar, Dheeraj Tran, Hiep Troconiz, I~ naki Turyan, Iva Vafa, Omid Vasquez, Maximiliano Vereb, Gyorgy Voelger, Hans-Rainer Von Kreudenstein, Thomas Von Pawel-Rammingen, Ulrich Vora, Kalpit W€achter, Dieter Walker, Adam Wang, Chenchen Wang, Jing Wang, Shunhai Wang, Siyang Wang, Weirong Wang, Zhan Ward, Sally Watier, Herve Wei, Xiaohui Weimer, Robby Weis, David Williams, Simon Wollacott, Rachel Wozniak Knopp, Gordana Wu, Anna Wu, Zhiwei Wuest, Frank Wycoff, Keith Xiao, Xiaodong Xiling, Jiang Xu, Yingda Yang, Tong-Yuan Yu, Li Yuan, Hua Zanardi, Elisa Zang, Li Zettl, Frank Zhang, Baolin Zhang, Boyan Zhang, Fan Zhang, Hao Zhang, Zhaorui Zheng, Chao Zheng, Songmao Zhou, Qinwei Zuberbuehler, Katherin

Institution University of Toronto Technical University of Munich National Institutes of Health (retired) Suppremol GmbH Bioprocessing Technology Institute, A*STAR MassBiologics of UMass Medical School Amgen Inc. Genentech Lonza Biologics plc National Institutes of Health University of Montreal Pfizer Inc. Genentech Independent consultant Eli Lilly and Company Janssen Research & Development, LLC Eli Lilly and Company University of Leiden University of Virginia Abbott Public Health Agency of Canada Pfizer Inc. Abzyme Therapeutics, LLC University of Navarra Biogen Teneobio Adimab, LLC University of Debrecen Roche Pharma Research & Early Development Zymeworks Inc.  Umea University Merck and Co. Inc. Vossius & Partner GlaxoSmithKline Plc Gilead Sciences, Inc. Tesaro Regeneron LakePharma Janssen Research & Development, LLC Regeneron Texas A&M Health Science Center CNRS, University of Tours Food and Drug Administration Genentech University of Kansas Genentech MassBiologics of UMass Medical School BOKU Geffen School of Medicine at UCLA Nanjing University University of Alberta Planet Biotechnology MedImmune, Inc. Janssen Research & Development, LLC Adimab, LLC Janssen Research & Development, LLC Roche Innovation Center New York Zoetis Fondazione IRCCS Istituto Nazionale dei Tumori Biogen Roche Diagnostics GmbH Food and Drug Administration Beijing Mabworks University of California Riverside Amgen AbbVie Inc. Boehringer Ingelheim Pharma GmbH & Co.KG Janssen Research & Development, LLC Eli Lilly and Company University of California San Francisco

Country Canada Germany United States Germany Singapore United States United States United States United Kingdom United States Canada United States United States United States United States United States United States The Netherlands United States United States Canada United States United States Spain United States United States United States Hungary Germany Canada Sweden United States Switzerland United Kingdom United States United States United States United States United States United States United States France United States United States United States United States United States Austria United States China Canada United States United States United States United States United States United States United States Italy United States Germany United States China United States United States United States United States United States United States United States

Note of appreciation to reviewers.

Note of appreciation to reviewers. - PDF Download Free
186KB Sizes 58 Downloads 10 Views